Literature DB >> 32144438

Tripping on nothing: placebo psychedelics and contextual factors.

Jay A Olson1, Léah Suissa-Rocheleau2, Michael Lifshitz3, Amir Raz4,5, Samuel P L Veissière4,6.   

Abstract

RATIONALE: Is it possible to have a psychedelic experience from a placebo alone? Most psychedelic studies find few effects in the placebo control group, yet these effects may have been obscured by the study design, setting, or analysis decisions.
OBJECTIVE: We examined individual variation in placebo effects in a naturalistic environment resembling a typical psychedelic party.
METHODS: Thirty-three students completed a single-arm study ostensibly examining how a psychedelic drug affects creativity. The 4-h study took place in a group setting with music, paintings, coloured lights, and visual projections. Participants consumed a placebo that we described as a drug resembling psilocybin, which is found in psychedelic mushrooms. To boost expectations, confederates subtly acted out the stated effects of the drug and participants were led to believe that there was no placebo control group. The participants later completed the 5-Dimensional Altered States of Consciousness Rating Scale, which measures changes in conscious experience.
RESULTS: There was considerable individual variation in the placebo effects; many participants reported no changes while others showed effects with magnitudes typically associated with moderate or high doses of psilocybin. In addition, the majority (61%) of participants verbally reported some effect of the drug. Several stated that they saw the paintings on the walls "move" or "reshape" themselves, others felt "heavy… as if gravity [had] a stronger hold", and one had a "come down" before another "wave" hit her.
CONCLUSION: Understanding how context and expectations promote psychedelic-like effects, even without the drug, will help researchers to isolate drug effects and clinicians to maximise their therapeutic potential.

Entities:  

Keywords:  Contact high; Context; Expectation; Placebo effects; Psilocybin; Setting

Year:  2020        PMID: 32144438     DOI: 10.1007/s00213-020-05464-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

Review 1.  Do psychedelics change beliefs?

Authors:  H T McGovern; P Leptourgos; B T Hutchinson; P R Corlett
Journal:  Psychopharmacology (Berl)       Date:  2022-05-04       Impact factor: 4.530

2.  Natural language signatures of psilocybin microdosing.

Authors:  Camila Sanz; Federico Cavanna; Stephanie Muller; Laura de la Fuente; Federico Zamberlan; Matías Palmucci; Lucie Janeckova; Martin Kuchar; Facundo Carrillo; Adolfo M García; Carla Pallavicini; Enzo Tagliazucchi
Journal:  Psychopharmacology (Berl)       Date:  2022-06-09       Impact factor: 4.415

Review 3.  Defining Transformative Experiences: A Conceptual Analysis.

Authors:  Alice Chirico; Marta Pizzolante; Alexandra Kitson; Elena Gianotti; Bernhard E Riecke; Andrea Gaggioli
Journal:  Front Psychol       Date:  2022-06-24

4.  Trait phenomenological control predicts experience of mirror synaesthesia and the rubber hand illusion.

Authors:  P Lush; V Botan; R B Scott; A K Seth; J Ward; Z Dienes
Journal:  Nat Commun       Date:  2020-09-25       Impact factor: 14.919

5.  Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes.

Authors:  Gabrielle Agin-Liebes; Trevor F Haas; Rafael Lancelotta; Malin V Uthaug; Johannes G Ramaekers; Alan K Davis
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-23

Review 6.  Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity.

Authors:  David E Olson
Journal:  Biochemistry       Date:  2022-01-21       Impact factor: 3.162

7.  Rhythmic Chanting and Mystical States across Traditions.

Authors:  Gemma Perry; Vince Polito; William Forde Thompson
Journal:  Brain Sci       Date:  2021-01-13

Review 8.  The Therapeutic Potential of Psilocybin.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Henkel Valentine; Justin Grant; Amza Ali; Wilfred Ngwa; Lorenzo Gordon
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411

9.  Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.

Authors:  Keri Mans; Hannes Kettner; David Erritzoe; Eline C H M Haijen; Mendel Kaelen; Robin L Carhart-Harris
Journal:  Front Psychiatry       Date:  2021-06-29       Impact factor: 4.157

10.  Amazonian Medicine and the Psychedelic Revival: Considering the "Dieta".

Authors:  David M O'Shaughnessy; Ilana Berlowitz
Journal:  Front Pharmacol       Date:  2021-05-28       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.